Skip to main content
. 2021 Oct 25;22(21):11488. doi: 10.3390/ijms222111488

Table 1.

Concepts on initiation and/or progression of human atherosclerotic lesion. Denomination: terminology used to describe the beginning of atherosclerotic lesion development. Features: hallmarks and triggers of lesion initiation. Lesion progression due to…: hallmarks and triggers of lesion progression (provided that lesion progression is considered).

Denomination Features Lesion Progression Due to … Ref.
fatty streak, minimal sudanophilic intimal deposit both intra- and extracellular “globules” of lipid, slight increase in interstitial mucinous material conversion into fibrous plaques [2]
type I (initial) lesion isolated macrophage foam cells small pools of lipid droplets and dead cell remnants as a source of extracellular lipid in addition to macrophage foam cells (preatheroma) [3,4]
intimal xanthoma isolated macrophage foam cells extracellular lipid accumulation (lipid pools) that are rich in extracellular matrix proteoglycans (pathologic intimal thickening (PIT)) [5,6,7]
grade of lipid deposition 1 fatty streaks with extracellular lipids colocalizing with biglycan and decorin in the outer layer of the intima n/a [8]
early lesion plasma albumin and apolipoprotein B insudation n/a [9]
early lesion interstitial lipid deposits resulting from the encrustation or imbibition of fibrin onto or into the intima n/a [10]
gelatinous lesion balances of intact LDL/“deposited” cholesterol and of fibrinogen/fibrin loss of steady state concentrations reflecting rates of egress of macromolecules depending on molecular sieving (immobilization of LDL by fibrin) [11]
n/a n/a influx-efflux imbalance in the cell and blood vessel wall [12]
epicardial coronary atherosclerosis impairment of lymphatic drainage from the coronary arteries (absence of a potential system for removing protein, fluid and lipids from the arterial wall) impairment of lymphatic drainage from the coronary arteries (absence of a potential system for removing protein, fluid and lipids from the arterial wall) [13]
prelesional stage ‘inert’ lipoprotein insudation without monocyte/ macrophage infiltration, lipoprotein modification and complement activation overload of the cholesterol removal machinery, enzymatic modification of LDL, complement activation, persisting macrophages secreting a variety of molecules accelerating lipoprotein retention, plaque instability, and clotting on rupture [14,15,16,17,18,19,20,21,22,23,24,25]
early fatty streak intracellular lipid accumulation in SMCs degeneration of lipid-containing cells with extravasation of lipid particles into the extracellular space [26]
early lesion ionic interaction of positively charged regions of apolipoprotein B with matrix proteins, including proteoglycans, collagen, and fibronectin n/a [27]
initial lipid deposition unesterified cholesterol-rich lipid particles n/a [28]
fatty streak LDL accumulation and oxidation preceding intimal accumulation of monocytes n/a [29]
n/a n/a cholesterol crystals or clefts in the musculoelastic (deep) layer of the intima or in the tunica media [30]
fatty streak accumulation of mononuclear cells n/a [31,32]
type I (initial) lesion alteration in electron density of the matrix of lysosomal bodies as well as the formation of lamellar bodies in lysosomes substantial structural changes of lysosomes in the ‘normal intima-initial lesion-fatty streak’ sequence [33,34]
early lesion unesterified, crystalline cholesterol n/a [35,36]
initial lesion miRNAs mediating cellular regulation in endothelial activation and inflammation, differentiation of macrophages and their polarization, having important functional properties in lipoprotein homeostasis and playing a central role in the mechanisms determining SMC phenotype miRNAs mediating cellular regulation in endothelial activation and inflammation, differentiation of macrophages and their polarization, having important functional properties in lipoprotein homeostasis and playing a central role in the mechanisms determining SMC phenotype [37,38,39,40,41]